these anti-osteoporitic drugs increase bone mass density and decrease osteoclastic bone resorption.
Bisphonates
Alendronate (fosamax) and risedronate (actonel)
Etidronate (didronel)
Teriparatide (forteo)
Calcitonin
Hormone replacement therapy
this drug is useful in paget's disease and heterotrophic ossification
etidronate (didronel)
this drug contains parathyroid hormone and raloxifene ( evista), a selective antiestrogen agent.
it is used for prevention in post menopausal women.
teriparatide (forteo)
this drug is a hormone ethat diminishes osteoclastic activity, is often admin as a nasal spray, and can be used for paget's disease but cannot prevent osteoporosis.
calcitonin
this therapy used estrogen plus progestin but has been discontinued due to increased risk of breast cancer and CV problems
hormone replacement therapy.
Author
BELISA78
ID
25810
Card Set
Osteoporosis agents or interventions
Description
review of nonpharm and pharmacological treatment of osteoporosis.